• Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
  • Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
  • Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
  • Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
  • Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
  • Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium

Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Powder
Purity: >99%
Samples:
US$ 80/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Bortezomib
Product Name
Bortezomib
Name
Bortezomib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
179324-69-7
Mf
C19h25bn4o4
Density
1.214
Melting Point
122-124 C
Storage Temperature
2-8 C
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
Pure CAS 179324-69-7 Bortezomib Powder Pharmaceutical Grade Bortezomib API Antitumor Bortezomib
Product Description
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin SodiumManufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
Product Details
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
 
Product Name Bortezomib
Name Bortezomib Powder
Purity 99%
CAS 179324-69-7
Appearance White powder
M.F C19H25BN4O4
Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a cancer of the blood. The reversible 26S proteasome Chemicalbook suppressor, a bar-shaped polyprotein particle, is present in the nucleus and cytoplasm of all eukaryotic cells. Targeting the ubiquitin-proteasome pathway. Drugs for the treatment of malignant tumors
Application&Function
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
Bortezomib was the first proteasome inhibitor to be used clinically. The proteasome is present in all eukaryotic cells and degrades over 80% of the proteins in the cell. It can reversibly inhibit the function of proteasome, thus inhibiting the Chemicalbook solution of protein, leading to protein accumulation and apoptosis. Because multiple myeloma (MM) continually replicates and secretes myeloma proteins, it is more sensitive to proteasomes than normal cells and can be used as a second-line treatment for MM and mantle cell lymphoma.
Specification
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin SodiumManufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin SodiumManufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin SodiumManufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
Manufacture Supply Heparin Sodium Raw Material Heparin Sodium Purity Heparin Sodium
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP